Use of platelet glycoprotein IIb/IIIa inhibitors in diabetics undergoing PCI for non-ST-segment elevation acute coronary syndromes: impact of clinical status and procedural characteristics

BACKGROUND: The most recent ESC guidelines for percutaneous coronary intervention (PCI) recommend the use of glycoprotein IIb/IIIa inhibitors (GPI) in high risk patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS), particularly in diabetics. Little is known about the adherence...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauer, Timm, Möllmann, Helge, Weidinger, Franz, Zeymer, Uwe, Seabra-Gomes, Ricardo, Eberli, Franz, Serruys, Patrick, Vahanian, Alec, Silber, Sigmund, Wijns, William, Hochadel, Matthias, Nef, Holger M., Hamm, Christian W., Marco, Jean, Gitt, Anselm K.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876272/
https://www.ncbi.nlm.nih.gov/pubmed/20186546
http://dx.doi.org/10.1007/s00392-010-0130-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876272/
https://www.ncbi.nlm.nih.gov/pubmed/20186546
http://dx.doi.org/10.1007/s00392-010-0130-1

Ejemplares similares